Atherosclerosis is a complex, multifactorial disease. Several studies have reported a possible association between infection with microbial agents and atherogenesis. Chlamydia pneumoniae (c. pneumoniae), Herpes Simplex Virus 1 (HSVI), Human Cytomegalovirus (HCMy), and Epstein Barr Virus (EBY) have been widely investigated for their possible role in atherosclerosis development, but the results obtained to date are contradictory. The aim of our study is to search DNA of the aforementioned infectious agents by means of Quantitative Real Time PCR in atherosclerotic plaques from carotid arteries obtained from 17 patients. Genomic sequences of C.pneumoniae, HSVI, HCMV were not found in any atherosclerotic lesion. Therefore, our results do not support the hypothesis of an association between these infectious agents and atherosclerosis. Conversely, three patients were found to be positive for EBV DNA, thus indicating that, at least in a limited number of patients, EBV could playa role in atherogenesis.
Systemic inflammation has been highlighted as a crucial factor in the pathogenesis of atherosclerosis (I). Therefore, a considerable number of seroepidemiological studies have attempted to demonstrate an association between atherosclerosis and infection, claiming that the array of ultra structural modifications induced in the vessel walls by specific pathogens could eventually promote atherogenesis. Several pathogens have been investigated as putative candidates of the atherosclerotic disease in many arterial districts such as coronary artery, carotid artery and abdominal aorta. In particular, Chlamydia pneumoniae (c. pneumoniae) and human herpesviruses (Herpes Simplex Virus I -HSVI-, Human Cytomegalovirus -HCMV-, and Epstein Barr Virus -EBV-), separately or in combination, have been variably associated with an increased risk of atherosclerosis. However, the results obtained from previous studies are quite contradictory (2) (3) (4) (5) (6) (7) .
The relevance of the aforementioned infective agents comes from the fact that herpesviruses could be atherogenic because of their potential ability to alter lipid metabolism in vascular cells, to injure endothelium, and to induce proliferation of smooth muscle cells and alteration of the hemostatic properties of the endothelium (8) . It is also hypothesized that C. pneumoniae is able to infect vascular endothelial cells and smooth muscle cells via the nuclear factor-kB pathway, resulting in increased expression of adhesion molecules, tissue factors and inflammatory cytokines (9) .
On the other hand, since large antibiotic trials fail to exert any valuable secondary prevention on the development of cardiovascular diseases (10), the infection hypothesis has been seriously questioned.
In this paper we investigated the presence of C. pneumoniae, HSVI, HCMV and EBV genome in atherosclerotic lesions obtained from carotid arteries during vascular surgery procedures. Interestingly, three out of 17 patients were found to be positive for EBV DNA.
MATERIALS AND METHODS

Patients and samples
The study was approved by our ethics review committee and informed consent was obtained from each patient participating in the study. Between May 2009 and October 2009 a total of 17 consecutive patients, requiring carotid endoarterectomy for significant carotid artery stenosis ( >70% narrowing of the lumen), were enrolled in the study. The epidemiological data and risk factors of these patients are summarized in Table I . Patients were assigned to smoker, hypertensive or diabetic groups according to ACC/AHA guidelines. Dyslipidemia was diagnosed if total cholesterol was > than 200 mgldl. In addition, 10 ml of venous blood was drawn for determination of: C-Reactive Protein (CRP), Alanine transaminase (ALT), Aspartate transaminase (AST), total cholesterol, and leukocytes (WBC).
Samples processing and DNA extraction
The plaque specimens removed at surgery from carotid arteries were placed under sterile conditions into plastic tubes containing PBS and were then cut into small pieces of 25 mg and stored at -80°C. DNA was isolated from tissue samples using the QIAamp Tissue Mini Kit (Qiagen, Germany) and following manufacturer's instructions. Quantification of DNA was carried out by using a spectrophotometer.
Quantitative Real Time res
The Quantitative Real Time PCR (Q-PCR) assays were performed using a 7300 Real Time PCR System and Taqman chemistry (Applied Biosystems, USA). The target regions were amplified by using primers and probes specific for~-globin gene, C. pneumoniae, HSV I, HCMV and EBY. The amplification of the human~-globin gene was performed in order to assess the presence and quality of the extracted DNA, by using primers and probe as previously published (II ).
DNA detection of C. Pneumoniae was performed by means of primers Cpmfor, Cpmrev and probe Cpmprobe, that have been previously reported by Tang The cycling conditions consisted of an initial denaturation at 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec and 60°C for I min. Each sample was analyzed in triplicate and each Q-PCR experiment contained a negative control, represented by the reaction mixture without DNA template. Ten-fold serial dilutions (from 1.1 x 10 4 copies/ul to l.l x 10 1 copies/ul) of plasmids containing C. pneumoniae, HSVl, HCMV, or EBV complete genomes (Advanced Biotechnologies Inc., USA) were used to construct a standard curve for the quantification of viral copies.
Data were expressed as viral copies per ug of DNA extracted from the tissue samples.
RESULTS
The p-globin gene was successfully amplified in all the tissue samples, confirming the good quality of the extracted nucleic acids and the lack of inhibitory factors within the reaction mixture. C. pneumoniae, HSVI, and HCMV DNA were not detected in any of the tested samples. Conversely, EBV DNA was amplified from atherosclerotic plaques derived from three different patients (17.6%). In one tissue sample, the virus was detected with a viral load of 100.3 copies/ug, whereas in the other two tissue samples the viral load was lower, corresponding to 6.3 copies/ug and 5.4 copies/ug (Table II) .
DISCUSSION
Q-PCR analysis was employed in our study to assess the presence ofC pneumoniae, HSV 1,HCMV, and EBV in atherosclerotic plaques collected from 17 patients who underwent carotid endoarterectomy for significant carotid artery stenosis. Our results failed to detect genomic DNA of C pneumoniae, HSVl, HCMV in any .of the analysed samples, whereas EBV DNA was detected in 3 out of 17 patients (17.6%). Therefore, the results seem to support the possibility that EBV, and not the other three investigated infectious agents, could be in some way involved in the pathogenesis of atherosclerosis. In this regard, it can be noted that the hypothesis of an association between EBV and the development of atherosclerotic plaques has been mainly supported by sero-epidemiological studies and, therefore, our findings are not easily comparable with other previously published works. Only a few studies have investigated atherosclerotic plaques for the presence of EBV DNA, with controversial results since some authors suggested a possible association (13) , whereas others failed to show the presence of EBV in the atherosclerotic plaques (3) .
The results regarding the finding of EBV DNA in 3 of the 17 analysed plaques need to be evaluated with caution, given: a) the low number of patients that showed positivity for the viral genome, b) the presence of a low viral load in two out of three positive plaques, c) the possibility of EBV infected leukocyte infiltration in atherosclerotic lesion, and d) the absence of a control group ofnon-atherosclerotic tissues. However, besides these concerns, it is well known that EBV is suggested as possible risk factor in several chronic inflammatory diseases, including multiple sclerosis (MS) (14) (15) . It has been in fact hypothesized that the virus may damage the myelin tissue by acting directly or through an immunemediated mechanism, thus contributing to MS development. Since in our experiments EBV DNA detection in the plaques may be related to leukocytes infiltration within the endothelial tissue, the data obtained could suggest a role for EBV as risk factor in the development of atherosclerotic plaques, similar to that hypothesized for MS demyelinating lesions.
In conclusion, our findings obtained from a limited number of samples do not support the hypothesis ofan association between C pneumoniae, HSVI, and HCMV infection and development of atherosclerosis. Conversely, our results indicate that EBV could playa role in the mechanisms that lead to the formation of the atherosclerotic plaques. However, further studies need to be performed on larger numbers to confirm our findings and to give further insights into the role of infectious agents as 
